|Day Low/High||15.40 / 16.55|
|52 Wk Low/High||5.61 / 25.10|
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CRON, SFS, TCS, TDW, TPRE Downgrades: AMBC, CARG, IRM, MUR, PEGI, RDFN, RL, TBI Initiations: RDVT Read on to get TheStreet Quant Ratings' detailed report:
Cronos announces that it has entered into a multi-year private label cannabis concentrate supply agreement MediPharm Labs.
The markets staged a big reversal Friday after the China tariffs and Uber's IPO thud. Jim Cramer's got your game plan for next week.
Jim Cramer takes a look at ADT, Domo, Aurora Cannabis, Seaspan, Walgreens Boots Alliance, Sirius XM Radio and more.
Cronos shares are falling despite easily topping analysts' earnings estimates.
Should you buy cannabis ETF instead of attempting to pick an individual stock?
The tobacco maker misses expectations in the first quarter on both the top and bottom lines. It reiterates 2019 earnings guidance.
Pot stocks may have cooled off in recent months but the industry is still hot and Bank of America Merrill Lynch expects it to get hotter as it reaches maturity.
It's 420. TheStreet's Jim Cramer discusses Canopy Growth, Tilray, Constellation Brands and other investing opportunities in the cannabis sector!
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
Bank of America doesn't see the cannabis market becoming mature in Canada until 2021.
Averages barely budge, despite grilling of banking CEOS by lawmakers. Jim Cramer talks about earnings and the great divide in Washington.
Jim Cramer takes a closer look at Yeti holdings, Tandem Diabetes Care, Electronic Arts, Aurora Cannabis, PacWest Bancorp and more.
Cannabis' non-psychoactive derivative could disrupt the CPG (Consumer Product Group) space very soon. Watch the video for the more on the opportunities and challenges.
Jim Cramer loves to see stories about worries at the start of earnings season. Lowered expectations are the best kind of expectations and they can make for great markets, he says.
Charts of this type are frequently found to be topping patterns.
Analysts at Canaccord downgrade the company's Canadian-traded stock to sell while maintaining a C$17 price target.
Cronos shares fall sharply after the cannabis company swings to a loss in the fiscal year.
While the two tobacco giants have similar yields, both also have very different businesses, with different growth potential in the years ahead.
Equity markets marked time on Monday, mostly on light volume.
Revenue is where it's at for cannabis in 2019.
A huge week is coming up for these well-known stocks.
Jim Cramer says there's so much money being run by computers, stocks are virtually destined to come down in this situation. Here's the game plan.
Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.
Overwhelmed by the cannabis earnings reports? Here's the metric that Jim Cramer watches.
Plus, why investors should care about the yield curve, and a closer look at Tilray's quarter.
Tilray shares turn following the company's fourth-quarter results while other pot stocks trade mixed.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.